BridgeMD
New treatment option for Stroke
Official title A Novel Rehabilitation Approach: Dyadic Strategy Training for Stroke Survivors and Their Caregivers
ClinicalTrials.gov ID: NCT05571150
What this study is testing
- What it's testing
- The purpose of this study is to examine the efficacy of a newly developed dyad-focused strategy training intervention on enhancing participation of stroke survivors and their caregivers. To address this purpose, a single-blinded, parallel-group randomized controlled trial will be implemented to assess the efficacy of the dyad-focused strategy training intervention in comparison to the control group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older. Healthy volunteers may be eligible.
You may be able to join if
- Stroke survivors
- ages 20 years and older;
- has been diagnosed with a first-time stroke within the past two year;
- speaks Mandarin;
- has an identified primary caregiver who provides care or assistance of any kind and taking responsibility for the survivor;
You likely can't join if
- The survivor-caregiver dyad will be excluded if any of them:
- requires significant medical treatment (e.g., chemotherapy, radiation therapy, or hemo/peritoneal dialysis) that may impede them from participating...
- has severe aphasia;
- is unable to participate in a 1-hour discussion session;
- has a diagnosis of dementia, major depressive disorder, substance use or other psychiatric disorders that may impede them from participating in the...
See the full eligibility criteria
- Stroke survivors
- ages 20 years and older;
- has been diagnosed with a first-time stroke within the past two year;
- speaks Mandarin;
- has an identified primary caregiver who provides care or assistance of any kind and taking responsibility for the survivor;
- is able to provide informed consent.
- Family caregivers include that the caregiver
- ages 20 years and older;
- speaks Mandarin;
- is the primary caregiver recognized by the survivor;
- is available to participate in the intervention sessions with the survivor;
- is able to provide informed consent.
- The survivor-caregiver dyad will be excluded if any of them:
- requires significant medical treatment (e.g., chemotherapy, radiation therapy, or hemo/peritoneal dialysis) that may impede them from participating in the study;
- has severe aphasia;
- is unable to participate in a 1-hour discussion session;
- has a diagnosis of dementia, major depressive disorder, substance use or other psychiatric disorders that may impede them from participating in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Taipei, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taipei, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.